Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group. [electronic resource]
Producer: 20111122Description: 863-70 p. digitalISSN:- 1432-0843
- Adenocarcinoma -- genetics
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- DNA-Binding Proteins -- genetics
- Esophageal Neoplasms -- genetics
- Female
- Genetic Variation
- Glutathione S-Transferase pi -- genetics
- Humans
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Radiation Injuries
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.